Receives Fda

• Elijah Dottery, diagnosed with sickle cell anemia as a baby, became the first U-M patient to receive the newly FDA-approved stem cell therapy. • The treatment uses patient's own stem cells edited via CRISPR to produce functional hemoglobin, administered at Michigan Medicine. • This breakthrough matters for over 100,000 U.S. sickle cell patients, offering potential cure where prior therapies only managed symptoms.

• Johnson & Johnson has received FDA approval for a new psoriasis treatment pill, expanding therapeutic options for patients with the chronic skin condition. • The United States smoking rate has quietly reached a historical low, reflecting decades of public health efforts and tobacco control policies. • These developments represent significant milestones in pharmaceutical innovation and public health outcomes across different therapeutic areas.